Region 5 Virtual Program: Beyond the Scales: Cardiometabolic Benefits of Today’s Anti-Obesity Agents
Description: Participants will examine the evolving landscape of obesity pharmacotherapy with a spotlight on the cardiovascular benefits of modern anti-obesity medications. The session will review current and emerging agents, summarize key clinical trials, and highlight evidence showing improvements in cardiovascular outcomes, including reductions in major adverse cardiovascular events, benefits in heart failure (especially HFpEF), and... Read more »